Cargando…

The Link between NAFLD and Metabolic Syndrome

Metabolic syndrome (MetS) is characterized by an association of cardiovascular and diabetes mellitus type 2 risk factors. Although the definition of MetS slightly differs depending on the society that described it, its central diagnostic criteria include impaired fasting glucose, low HDL-cholesterol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radu, Fabiana, Potcovaru, Claudia-Gabriela, Salmen, Teodor, Filip, Petruța Violeta, Pop, Corina, Fierbințeanu-Braticievici, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955701/ https://www.ncbi.nlm.nih.gov/pubmed/36832102 http://dx.doi.org/10.3390/diagnostics13040614

Ejemplares similares

Diagnostic Criteria and Prognostic Relevance of Sarcopenia in Patients with Inflammatory Bowel Disease—A Systematic Review
por: Potcovaru, Claudia-Gabriela, et al.
Publicado: (2023)

How and why do we screen for colorectal cancer?
por: Chetroiu, Diana, et al.
Publicado: (2021)

Correlation of Biomarkers with Endoscopic Score: Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in Patients with Ulcerative Colitis in Remission
por: Pop, Corina Silvia, et al.
Publicado: (2020)

MALT lymphoma: epidemiology, clinical diagnosis and treatment
por: Violeta Filip, Petruta, et al.
Publicado: (2018)

Evaluating the Adipose Tissue Depth as a Predictor Factor for Gestational Diabetes in Later Pregnancy—A Systematic Review
por: Salmen, Bianca-Margareta, et al.
Publicado: (2023)

Molecular Mechanisms of NAFLD in Metabolic Syndrome
por: Martins, Maria João, et al.
Publicado: (2015)

Antidiabetic Molecule Efficacy in Patients with Type 2 Diabetes Mellitus—A Real-Life Clinical Practice Study
por: Salmen, Teodor, et al.
Publicado: (2023)

The Safety Profile of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide 1 Receptor Agonists in the Standard of Care Treatment of Type 2 Diabetes Mellitus
por: Salmen, Teodor, et al.
Publicado: (2023)

Dysregulated lipid metabolism links NAFLD to cardiovascular disease
por: Deprince, Audrey, et al.
Publicado: (2020)

Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome
por: Wainwright, Patrick, et al.
Publicado: (2016)

The Impact of Increased Fib-4 Score in Patients with Type II Diabetes Mellitus on COVID-19 Disease Prognosis
por: Calapod, Ovidiu P., et al.
Publicado: (2021)

A pilot sentinel surveillance system to monitor treatment and treatment outcomes of chronic hepatitis B and C infections in clinical centres in three European countries, 2019
por: Nardone, Anthony, et al.
Publicado: (2023)

The Effects of Cardioprotective Antidiabetic Therapy on Microbiota in Patients with Type 2 Diabetes Mellitus—A Systematic Review
por: Bica, Ioana-Cristina, et al.
Publicado: (2023)

Molecular Interactions between NAFLD and Xenobiotic Metabolism
por: Naik, Adviti, et al.
Publicado: (2013)

Links between Metabolic Syndrome and Hypertension: The Relationship with the Current Antidiabetic Drugs
por: Stanciu, Silviu, et al.
Publicado: (2023)

From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome?
por: MUNTEANU, MIHAI ALEXANDRU, et al.
Publicado: (2014)

NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome
por: Michelotti, Anna, et al.
Publicado: (2021)

Investigating microRNAs to Explain the Link between Cholesterol Metabolism and NAFLD in Humans: A Systematic Review
por: Konings, Maurice C. J. M., et al.
Publicado: (2022)

Regulation of Cholesterol Metabolism in Liver: Link to NAFLD and Impact of n-3 PUFAs
por: Bae, Jin-Sik, et al.
Publicado: (2013)

Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD
por: Linge, Jennifer, et al.
Publicado: (2020)

NAFLD in Polycystic Ovary Syndrome: Association with PNPLA3 and Metabolic Features
por: Recuero, Amanda Medeiros, et al.
Publicado: (2022)

Association between metabolic syndrome and liver histology among NAFLD patients without diabetes
por: Kanwar, Pushpjeet, et al.
Publicado: (2016)

NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
por: Godoy-Matos, Amélio F., et al.
Publicado: (2020)

Is Metabolic Syndrome Useful for Identifying Youths with Obesity at Risk for NAFLD?
por: Di Bonito, Procolo, et al.
Publicado: (2023)

Comorbidities and Metabolic Derangement of NAFLD
por: Bang, Ki Bae, et al.
Publicado: (2015)

Metabolic Changes of Hepatocytes in NAFLD
por: Lu, Qianrang, et al.
Publicado: (2021)

Adherence to Mediterranean Diet and NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study
por: Montemayor, Sofía, et al.
Publicado: (2022)

Growth hormone deficiency and NAFLD: An overlooked and underrecognized link
por: Doycheva, Iliana, et al.
Publicado: (2022)

Is There a Link between Basal Metabolic Rate, Spleen Volume and Hepatic Growth Factor Levels in Patients with Obesity-Related NAFLD?
por: Tarantino, Giovanni, et al.
Publicado: (2019)

NAFLD - A rising metabolic disease
por: Zeigerer, Anja
Publicado: (2021)

MON-230 Androgen-Induced Disruption of the Biological Clock: The Link between PCOS and NAFLD
por: Abudu, Aierken, et al.
Publicado: (2019)

MD2 AMP(K)s up the link between lipid accumulation and inflammation in NAFLD
por: Heldens, Anneleen, et al.
Publicado: (2022)

Effect of Omega‐3 Polyunsaturated Fatty Acids on Lipid Metabolism in Patients With Metabolic Syndrome and NAFLD
por: Šmíd, Václav, et al.
Publicado: (2022)

The Link between the Metabolic Syndrome and Cancer
por: Braun, Sandra, et al.
Publicado: (2011)

Links between metabolic syndrome and the microbiome
por: Gildner, Theresa E
Publicado: (2020)

Endothelial Dysfunction, a Marker of Atherosclerosis, Is Independent of Metabolic Syndrome in NAFLD Patients
por: Narayan, Jimmy, et al.
Publicado: (2020)

Intrahepatic Fat Content and COVID-19 Lockdown in Adults with NAFLD and Metabolic Syndrome
por: Montemayor, Sofía, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines
por: Gangopadhyay, Anwesha, et al.
Publicado: (2022)

A Comparison of (13)C-Methacetin and (13)C-Octanoate Breath Test for the Evaluation of Nonalcoholic Steatohepatitis
por: Fierbinteanu-Braticevici, Carmen, et al.
Publicado: (2023)

Helicobacter pylori infection: old and new
por: Diaconu, S, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1eqj9122or6tfjpnvladei5bkm